These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 667865)

  • 21. [Symptoms and criteria of abnormalities: pulse].
    Ota A
    Kango Gijutsu; 1979 Oct; 25(14):63-71. PubMed ID: 259136
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of a 1-hour IV infusion of doxorubicin on the development of cardiotoxicity in dogs as evaluated by electrocardiography and echocardiography.
    Gillings S; Johnson J; Fulmer A; Hauck M
    Vet Ther; 2009; 10(1-2):46-58. PubMed ID: 19742448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Is the use of adriamycin (doxorubicin) limited by its cardiotoxicity?].
    Reinhardt D; Hofmann V; Martz G
    Schweiz Med Wochenschr; 1985 Apr; 115(16):557-61. PubMed ID: 4001904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity.
    Weiss AJ; Metter GE; Fletcher WS; Wilson WL; Grage TB; Ramirez G
    Cancer Treat Rep; 1976 Jul; 60(7):813-22. PubMed ID: 795537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Is cardiotoxicity of chemotherapy a problem of the oncologist or also the cardiologist?].
    Pudil R; Horácek JM
    Vnitr Lek; 2006 Apr; 52(4):306-7. PubMed ID: 16755985
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiotoxicity in children treated with anthracyclines: the role of M-mode echocardiography.
    Galli MA; Conter V; Zanetto F; Jankovic M; Ferrari L; Baio G; Masera G
    Haematologica; 1987; 72(4):347-50. PubMed ID: 3117636
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiomyopathy in adults after combination adriamycin and DTIC.
    Beretta G; Villani F
    Cancer Treat Rep; 1980; 64(2-3):353. PubMed ID: 7407770
    [No Abstract]   [Full Text] [Related]  

  • 28. A clinicopathologic analysis of adriamycin cardiotoxicity.
    Lefrak EA; Pitha J; Rosenheim S; Gottlieb JA
    Cancer; 1973 Aug; 32(2):302-14. PubMed ID: 4353012
    [No Abstract]   [Full Text] [Related]  

  • 29. [The significance of notches or bites in the vectorcardiogram. Study in cardiopathy caused by adriamycin].
    Vitolo E; Madoi S; Roveda M; Larovere MT; Beretta G; Obbiassi M
    Boll Soc Ital Cardiol; 1980; 25(9):1073-5. PubMed ID: 7284195
    [No Abstract]   [Full Text] [Related]  

  • 30. [Serial echocardiographic evaluation of subjects treated with adriamycin].
    Messina L; Palmieri S; Bonnì G; D'Alessandro N; Rausa L; Raineri A
    Boll Soc Ital Cardiol; 1981; 26(12):2231-7. PubMed ID: 7185392
    [No Abstract]   [Full Text] [Related]  

  • 31. Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats.
    Puri A; Maulik SK; Ray R; Bhatnagar V
    Eur J Pediatr Surg; 2005 Dec; 15(6):387-91. PubMed ID: 16418954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of diltiazem on the cardiotoxicity induced by adriamycin in rabbits.
    Mochizuki T; Okazaki T; Ishikura H; Izumi Y; Tashima M; Sawada H; Uchino H; Konishi T; Ikeguchi S; Takasu K
    Nihon Gan Chiryo Gakkai Shi; 1987 Apr; 22(3):539-49. PubMed ID: 3655481
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic involvement in adriamycin cardiotoxicity.
    Seraydarian MW; Artaza L; Yang JJ
    Adv Myocardiol; 1980; 2():213-23. PubMed ID: 7423039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum carnitine levels during the doxorubicin therapy. Its role in cardiotoxicity.
    Yaris N; Ceviz N; Coskun T; Akytüz C; Büyükpamukçu M
    J Exp Clin Cancer Res; 2002 Jun; 21(2):165-70. PubMed ID: 12148572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes.
    Working PK; Newman MS; Sullivan T; Yarrington J
    J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxorubicin-induced cardiotoxicity.
    Paz-Ares L; Dobbs N; Twelves C
    N Engl J Med; 1995 Nov; 333(20):1360. PubMed ID: 7566044
    [No Abstract]   [Full Text] [Related]  

  • 37. Editorial: Adriamycin and the heart.
    Lancet; 1974 Jun; 1(7870):1325. PubMed ID: 4134302
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cardiac risks of adriamycin. Early detection of high-risk patients by isotopic cardiac function study].
    Pecking A; Delorme G; Berlie J; Goupil A; Tubiana M; Turpin F; Meeus L; Clavel B
    Presse Med; 1983 Nov; 12(39):2445-8. PubMed ID: 6227889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity.
    Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ
    Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin-induced cardiotoxicity.
    Silber JH; Barber G
    N Engl J Med; 1995 Nov; 333(20):1359-60. PubMed ID: 7566043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.